As Americans continue to struggle to afford their medical bills, and some newly insured under the Affordable Care Act find they can’t afford to use the coverage they purchased, finding the “right” health insurance plan is important.
As Americans continue to struggle to afford their medical bills, and some newly insured under the Affordable Care Act find they can’t afford to use the coverage they purchased, finding the “right” health insurance plan is important.
The University of Michigan Center for Value-Based Insurance Design, led by A. Mark Fendrick, MD, director of the center and co-editor-in-chief of The American Journal of Managed Care, has released a new whiteboard video highlighting the benefits of a value-based insurance design (VBID) plan.
In the video, Goldilocks Choose a Health Plan, the titular character tries out a health plan that is “too soft,” which may cover many services, have a broad provider network, and include low cost-sharing, but also encourages wasteful spending and will be subject to the Cadillac tax. She also looks at a plan that is “too hard,” with high deductibles, narrow networks, and few covered services before the deductible and which could worsen health disparities and lead to adverse health outcomes.
The VBID plan ends up being “just right” by lowering cost-sharing for high-value services, discouraging use of services with no proven value, and an affordable price. Watch the full video from the VBID Center.
Recently, CMS announced that it would be holding a 5-year demonstration in 7 states of VBID in Medicare Advantage.
“The 5-year model will look, at the end, to see if lowering cost-sharing for high-value services and providers will meet the triple aim of better quality of care, better patient experience, and lower healthcare costs,” explained Dr Fendrick.
He also outlined that some of the hurdles that need to be overcome with the demonstration are concerns about who will enroll and if people understand and take advantage of the lower cost-sharing.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More